高雄醫學大學 |
2007 |
在一B型與C型肝炎高盛行區C型肝炎病毒血症增加第二型糖尿病的相關性
|
黃志富;戴嘉言;黃尚志;何啟功;蕭璧容;謝明彥;李立柏;林子堯;陳信成;謝明裕;王良彥;辛錫璋;張文宇;莊萬龍; , 余明隆; Huang, JF;Dai, CY;Hwang, SJ;Ho, CK;Hsiao, PJ;Hsieh, MY;Lee, LP;Lin, ZY;Chen, SC;Hsieh, MY;Wang, LY;Shin, SJ;Chang, WY;Chuang, WL;ML , Yu |
高雄醫學大學 |
2007 |
The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C
|
戴嘉言;黃志富;謝明彥;李立柏;何啟功;莊萬龍;余明隆; Dai, CY;Huang, JF;Hsieh, MY;Lee, LP;Ho, CK;Chuang, WL;Yu, ML |
高雄醫學大學 |
2007 |
慢性C型肝炎患者抗核抗體(ANA)陽性率對臨床表徵及對干擾素合併ribavirin治療療效之影響
|
謝明彥; Hsieh, Ming-Yen |
高雄醫學大學 |
2007 |
慢性C型肝炎患者抗核抗體(ANA)陽性率對臨床表徵及對干擾素合併ribavirin治療療效之影響
|
謝明彥; Hsieh, Ming-Yen |
高雄醫學大學 |
2007 |
Hepatitis C viremia increases risk of type 2 diabetes mellitus in a hepatitis B and C endemic area
|
黃志富;余明隆;莊萬隆;戴嘉言;何啟功;李立柏;謝明彥;林子堯;陳信成;謝明裕;辛錫璋;張文宇 |
高雄醫學大學 |
2007 |
The HBV Infection Among Aboriginal Children 20 Years After Immunization In Taiwan
|
莊萬龍;余明隆;戴嘉言;何啟功;黃釧峰;侯乃仁;李立柏;謝明彥;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇 |
高雄醫學大學 |
2007 |
HEPATIC SPLENOSIS – TWO CASES REPORT
|
葉明倫;王良彥;黃駿逸;謝明彥;陳信成;林子堯;莊萬龍;張文燦;李金德;蔡志仁;劉金昌 |
高雄醫學大學 |
2007 |
干安能治療B型肝炎引起失償非肝硬化病患早期死亡率及反應-以MELD及INDEX指標評估
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
高雄醫學大學 |
2007 |
The antinuclear antibody is associated with lower RNA levels of hepatitis C virus and more advanced fibrosis in chronic hepatitis C patients
|
謝明彥;黃志富;侯乃仁;戴嘉言;李立柏;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍;余明隆 |
高雄醫學大學 |
2007 |
Almost all HCV G2 Pts With Rapid Virologic Response at Wk 4 Achieve a SVR With 16 Wks of Treatment
|
余明隆;戴嘉言;黃志富;侯乃仁;李立柏;謝明彥;丘長富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
高雄醫學大學 |
2007 |
Outcome of chronic hepatitis C patients who required early termination of peginterferon-alfa plus ribavirin combination therapy
|
余明隆;戴嘉言;謝明彥;黃志富;張文宇;莊萬龍 |
高雄醫學大學 |
2007 |
Evaluation of the Abbott HCV RealTime PCR Assay for quantification of HCV viral loads
|
莊萬龍;黃志富;余明隆;戴嘉言;李立柏;謝明彥;林子堯;陳信成;謝明裕;張文宇 |
高雄醫學大學 |
2007 |
Human leukocyte antigen class I and II alleles and response to peginterferon plus ribavirin combination therapy in chronic hepatitis C patients
|
莊萬龍;戴嘉言;謝明彥;黃志富;張文宇;余明隆 |
高雄醫學大學 |
2007 |
Different Features In Liver Histopathology Of HCV Monoinfection And HCV/HBV Dual Infection
|
李立柏;余明隆;戴嘉言;侯乃仁;謝明彥;林子堯;陳信成;謝明裕;王良彥;Chen, Tong-Jong;張文宇;莊萬龍 |
高雄醫學大學 |
2007 |
The Seroprevalence Of HBV And HCV Infection In Southern Taiwan- Large Scale Community-Based Study
|
莊萬龍;余明隆;戴嘉言;林嘉益;侯乃仁;李立柏;謝明彥;黃志富;謝明裕;張文宇 |
高雄醫學大學 |
2007 |
Transforming Growth Factor-Beta 1 Gene Polymorphisms In High Dose IFN/Ribavirin treated CHC Patients
|
戴嘉言;余明隆;張文宇;李立柏;潘文正;侯乃仁;謝明彥;黃志富;陳信成;林子堯;謝明裕;王良彥;莊萬龍 |
高雄醫學大學 |
2007 |
Early Mortality And Responses In Non-Cirrhotic Decompensated CHB Patients With Lamivudine Therapy
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;陳信成;王良彥;張文宇;莊萬龍 |
高雄醫學大學 |
2007 |
EARLY MORTALITY AND RESPONSES IN NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS B-RELATED DECOMPENSATION WITH LAMIVUDINE THERAPY: EVALUATION OF MELD AND INDEX SCORING SYSTEMS AS PROGNOSTIC PREDICTORS
|
戴嘉言;余明隆;侯乃仁;謝明彥;李立柏;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 |
高雄醫學大學 |
2007 |
The presence of Antinuclear Antibody is associated with a negative response to combination therapy with peginterferon and ribavirin for patients without genotype 1 chronic hepatitis C infection
|
謝明彥;戴嘉言;黃志富;莊萬龍;侯乃仁;李立柏;陳信成;謝明裕;王良彥;張文宇;余明隆 |
高雄醫學大學 |
2007 |
High chance of cure in HCV genotype 1 patients with a low viral load achieving an RVR treated for 24 wks with pegylated interferon alfa-2a (PEGASYS) plus ribavirin (COPEGUS): Prospective, randomized, controlled study comparing 24 & 48 wks of treatm
|
余明隆;戴嘉言;黃志富;李立柏;謝明彥;丘長富;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍* |
高雄醫學大學 |
2007 |
PHARMACOGENOMICS STUDY FOR 24 VS. 48 WEEKS TREATMENT OF PEGINTERFERON PLUS RIBAVIRIN FOR GENOTYPE 1b CHRONIC HEPATITIS C
|
戴嘉言;黃志富;謝明彥;陳信成;余明隆;莊萬龍 |
高雄醫學大學 |
2007 |
RELATIONSHIP BETWEEN GLUCOSE ABNORMALITIES AND RESPONSE TO PEGYLATED INTERFERON ALFA PLUS RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C PATIENTS
|
謝明彥;戴嘉言;黃志富;林子堯;余明隆;莊萬龍 |
高雄醫學大學 |
2007 |
葡萄糖異常與慢性C型肝炎患者接受長效型干擾素(pegylated interferon alfa)合併ribavirin治療反應之關聯性研究
|
謝明彥;戴嘉言;李立柏;余明隆;王良彥;莊萬龍;張文宇 |
高雄醫學大學 |
2006 |
A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan.
|
余明隆;戴嘉言;林子堯;李立柏;侯乃仁;謝明彥;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Ming-Lung Yu;Chia-Yen Dai;Zu-Yau Lin;Li-Po Lee;Nei-Jen Hou;Ming-Yen Hsieh;Shinn-Cherng Chen;Ming-Yuh Hsieh;Liang-Yen Wang;Wen-Yu Chang;Wan-Long Chuang |
高雄醫學大學 |
2006 |
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
|
余明隆;戴嘉言;李立柏;謝明彥;侯乃仁;黃志富;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍 ; Yu ML;Dai CY;Lee LP;Hsieh MY;Hou NJ;Huang JF;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Chuang WL |